Reliability of resting-state electrophysiology in fragile X syndrome

Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Rui Liu, Ernest V. Pedapati, Lauren M. Schmitt, Rebecca C. Shaffer, Elizabeth G. Smith, Kelli C. Dominick, Lisa A. DeStefano, Grace Westerkamp, Paul Horn, John A. Sweeney, Craig A. Erickson
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2023-12-01
Saila:Biomarkers in Neuropsychiatry
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2666144623000102